ENTA
Enanta Pharmaceuticals Inc
Price:  
7.14 
USD
Volume:  
419,283.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA WACC - Weighted Average Cost of Capital

The WACC of Enanta Pharmaceuticals Inc (ENTA) is 9.1%.

The Cost of Equity of Enanta Pharmaceuticals Inc (ENTA) is 8.30%.
The Cost of Debt of Enanta Pharmaceuticals Inc (ENTA) is 108.05%.

Range Selected
Cost of equity 7.00% - 9.60% 8.30%
Tax rate 1.90% - 2.50% 2.20%
Cost of debt 7.00% - 209.10% 108.05%
WACC 7.0% - 11.3% 9.1%
WACC

ENTA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.67 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 9.60%
Tax rate 1.90% 2.50%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 209.10%
After-tax WACC 7.0% 11.3%
Selected WACC 9.1%